source
- Roche launches VENTANA BAP1 test to improve mesothelioma diagnosisRoche announced the global launch of its VENTANA BAP1 (SP527) test, an automated ready‑to‑use immunohistochemistry assay designed for differential diagnosis of mesothelioma. The assay targets the…
- Third Rock partner’s brain cancer diagnosis highlights personal impact of biotech drug developmentJigar Raythatha, a partner at Third Rock Ventures, was diagnosed with a rare form of brain cancer in 2023 after a routine MRI. On the same day his diagnosis was confirmed, Servier announced posit…